More SEC Filings
View Older Stories View Newer Stories-
Form 497K ALPS ETF Trust
-
Form 424B2 GOLDMAN SACHS GROUP INC
-
Form 4/A HANMI FINANCIAL CORP For: Mar 26 Filed by: Kim Anthony I.
-
Form 144 INSMED Inc Filed by: Lewis William
-
Form DEFA14A CROWN CASTLE INC.
-
Form 4 UNITED THERAPEUTICS Corp For: Apr 02 Filed by: ROTHBLATT MARTINE A
-
Form 424B2 GOLDMAN SACHS GROUP INC
-
Form D/A Sempreverde Global Equit
-
Form 424B2 GOLDMAN SACHS GROUP INC
-
Form 4 UNITED THERAPEUTICS Corp For: Apr 02 Filed by: EDGEMOND JAMES
-
Form ARS Immix Biopharma, Inc. For: Dec 31
-
Form 424B2 MORGAN STANLEY
-
Form 4 GAP INC For: Apr 02 Filed by: FISHER ROBERT J
-
Form 497K ALPS ETF Trust
-
Form 6-K Intercont (Cayman) Ltd For: Dec 31
-
Form 424B2 GOLDMAN SACHS GROUP INC
-
Form 424B2 UBS AG
-
Form SCHEDULE 13D/A Compass Diversified Hold Filed by: ADW Capital Partners, L.P.
-
Form 4 MID AMERICA APARTMENT For: Apr 01 Filed by: BOLTON H ERIC JR
-
Form 4 SHORE BANCSHARES INC For: Apr 02 Filed by: WAYSON KONRAD
-
Form SCHEDULE 13G/A Indaptus Therapeutics, Filed by: YA II PN, Ltd.
-
Form 8-K Neuronetics, Inc. For: Mar 31
-
Form 4/A LINDBLAD EXPEDITIONS For: Mar 31 Filed by: Leahy Natalya
-
Form 424B2 GOLDMAN SACHS GROUP INC
-
Form 497J DELAWARE GROUP GLOBAL &
-
Form 424B2 UBS AG
-
Form 497J DELAWARE GROUP EQUITY
-
Form ARS FB Financial Corp For: Dec 31
-
Form 424B2 UBS AG
-
Form 497J DELAWARE GROUP EQUITY
-
Form DEFA14A Immix Biopharma, Inc.
-
Form 424B2 UBS AG
-
Form 424B2 UBS AG
-
Form 424B2 JPMORGAN CHASE & CO
-
Form 424B2 NXG NextGen Infrastructu
-
Form D/A Doma Perpetual LO Equity
-
Form 424B2 UBS AG
-
Form 424B2 UBS AG
-
Form 424B2 CITIGROUP INC
-
Form 424B2 UBS AG
-
Form 424B2 GOLDMAN SACHS GROUP INC
-
Form 424B2 UBS AG
-
Form 4 Elauwit Connection, Inc. For: Apr 02 Filed by: Huffman Kyle E.
-
Form 4 MID AMERICA APARTMENT For: Apr 01 Filed by: Carpenter Melanie
-
Form 4 Total Return Securities For: Apr 02 Filed by: Dakos Andrew
-
Form 4 Elauwit Connection, Inc. For: Apr 02 Filed by: Barton Scott Winter
-
Form 144 Arqit Quantum Inc. Filed by: Leaver Andrew
-
Form DEF 14A Immix Biopharma, Inc. For: Apr 06
-
Form 424B2 UBS AG
-
Form D Sequoia Capital Growth

